Medtech
Apple’s research into non-invasive glucose monitoring remains ongoing.
Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp.
The group has bought 11 businesses in the past seven years.
It was a pretty good year for the stock market, but how about for biotech stocks?
The military reviewed bids from 31 suitors and is good to Dec. 20, 2022.
Taris is developing implanted, continuous delivery devices combined with known cancer drugs for bladder disease treatment.
Many people will be surprised to learn that Theranos is still open and doing business, let alone to be able to acquire a $100M loan.
The U.S. Food and Drug Administration on Friday said it plans to let medical device makers report less serious malfunctions of some devices on a quarterly basis to cut down on repeated reviews of common problems.
For the first time in years, the medical device tax will take effect Jan. 1, after Congress left town without delivering on a long-promised delay or repeal.
PRESS RELEASES